نتایج جستجو برای: نظریه منبع محور rbv

تعداد نتایج: 69073  

2012
Kan Fujino Masayuki Horie Tomoyuki Honda Shoko Nakamura Yusuke Matsumoto Ivo M. B. Francischetti Keizo Tomonaga

Bornavirus, a non-segmented, negative-strand RNA viruses, is currently classified into several genetically distinct genotypes, such as Borna disease virus (BDV) and avian bornaviruses (ABVs). Recent studies revealed that bornavirus genotypes show unique sequence variability in the putative 5' untranslated region (5' UTR) of X/P mRNA, a bicistronic mRNA for the X protein and phosphoprotein (P). ...

Journal: :American journal of physiology. Heart and circulatory physiology 2007
Nathan T Kuipers Charity L Sauder Matthew L Kearney Chester A Ray

The purpose of the present study was to examine the effect of heating and cooling the forearm muscles on renal vascular responses to ischemic isometric handgrip (IHG). It was hypothesized that heating and cooling the forearm would augment and attenuate, respectively, renal vascular responses to IHG. Renal vascular responses to IHG were studied during forearm heating at 39 degrees C (n = 15, 26 ...

Journal: :The Journal of general virology 1999
H Matsumura N Ikemura Y Ito K Kuribayashi

The V gene of the paramyxovirus human parainfluenza virus type 2 (hPIV2) is transcribed into both V and P mRNA. The V mRNA is a faithful transcript of the V gene; however, the P mRNA is transcribed by an RNA-editing mechanism in hPIV2-infected mammalian cells. Recombinant baculoviruses (rBV) were constructed containing the wild-type V gene, which has seven G residues at its editing site, and a ...

2015
Bassem Refaat Adel Galal El-Shemi Ahmed Mohamed Ashshi Elaf Wael Mahamid Noha Mohammed Al-Qadi

AIMS To measure the expression of activin βA-subunit, activin IIA and IIB receptors, Smad4, Smad7, and follistatin in the liver and the liver and serum concentrations of mature activin-A and follistatin in normal rat following treatment with pegylated interferon-α (Peg-INF-α) and ribavirin (RBV). MATERIALS AND METHODS 40 male Wistar rats were divided equally into 4 groups: "control," "Peg-onl...

در شرایط پیچیده و چالشی دنیای کسب‌و‌کار، فعالان اقتصادی به‌دنبال راهبردهای نوین جهت غلبه بر ریسک‌های پیش‌رو هستند. یکی از رویکردهای جدید درحوزه کسب وکار، تغییر در نوع روابط بنگاه ها با رقبای خود در یک صنعت و حرکت به سمت همکاری و تعامل بیشتر با رقبا می‌باشد که از آن تحت عنوان "هم‌رقابتی"، یاد می‌شود. این رویکرد که به تضادی در ادبیات مدیریت استراتژیک تبدیل شده از دیدگاههای نظری مختلفی مورد بررسی ...

Journal: :hepatitis monthly 0
yoshio aizawa department of gastroenterology and hepatology, jikei university school of medicine, tokyo, japan; department of gastroenterology and hepatology, jikei university school of medicine, tokyo, japan , +81-336032111 noritomo shimada department of gastroenterology and hepatology, shinmatsudo chuo general hospital, chiba, japan hiroshi abe department of gastroenterology and hepatology, jikei university school of medicine, tokyo, japan nobuyoshi seki department of gastroenterology and hepatology, jikei university school of medicine, tokyo, japan yuta aida department of gastroenterology and hepatology, jikei university school of medicine, tokyo, japan haruya ishiguro department of gastroenterology and hepatology, jikei university school of medicine, tokyo, japan

conclusions examination of the fasting lipid profile has clinical importance in predicting the efficacy of peg-ifn-α-2b plus rbv combination therapy for patients with hcv g1b even after the discovery of the il28 genotype as a potent predictive factor. objectives to re-examine the significance of lipoprotein profiles on virological response to peg-ifn plus rbv combination therapy in patients wit...

ژورنال: :اندیشه مدیریت راهبردی 2009
بهمن حاجی پور مصطفی مؤمنی

حفظ بقای سازمان ها در محیط رقابتی دنیای امروز، راهی جز کسب مزیت رقابتی برای آنها باقی نمی گذارد. نظریه پردازان علم مدیریت استراتژیک دو رویکرد عمده برای کسب مزیت رقابتی مطرح نموده اند؛ رویکردی که مبتنی بر فرصت های محیطی و رویکردی که مبتنی بر قابلیت های داخلی سازمان است. پژوهش های دو دهه اخیر نشان داده اند مزیت های مبتنی بر قابلیت های درونی سازمان ها بهتر از فرصت های محیطی می توانند موقعیت رقابتی...

Journal: :hepatitis monthly 0
bita behnava iran hepatitis network, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran heidar sharafi iran hepatitis network, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases, baqiyatallah university of medical sciences, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran; armin pathobiology laboratory, tehran, ir iran maryam keshvari iran hepatitis network, tehran, ir iran; blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran ali pouryasin iran hepatitis network, tehran, ir iran; armin pathobiology laboratory, tehran, ir iran; department of biology, arsanjan branch, islamic azad university, arsanjan, ir iran leila mehrnoush iran hepatitis network, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran shima salimi iran hepatitis network, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran

patients and methods this cross - sectional study was conducted on 143 thalassemic patients with chronic hepatitis c, who were treated with a combination of peg-ifn and rbv regimen. the rs12979860 and rs8099917 polymorphisms were assessed as the most common polymorphisms near the il28b gene by the polymerase chain reaction-restriction fragment length polymorphism (pcr-rflp) method. objectives w...

Journal: :Journal of Viral Hepatitis 2007
Th Witthöft B Möller K H Wiedmann St Mauss R Link J Lohmeyer M Lafrenz C M Gelbmann D Hüppe C Niederau U Alshuth

The combination treatment of peginterferon alpha-2a (PEG-IFN alpha-2a; Pegasys) plus ribavirin (RBV) is recommended as a standard care for HCV infections. Side effects and aspects of efficacy and safety have to be balanced. This study evaluates clinical practice data on safety and efficacy of HCV treatment with PEG-IFN in combination with RBV over 24 and 48 weeks. This study was a phase III, mu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید